Sign inJoin waitlistJoin the waitlist

Randall Ow

Physician · Capital Allergy and Respiratory Disease Center A Med Corp

Credentials: · · ·

History

Capital Allergy and Respiratory Disease Center A Med Corp
2026–Present

Otolaryngology
1989–1994
F. Edward Hébert School of Medicine
1985–1989

Research

Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
Journal of Allergy and Clinical Immunology · 2022 · 107 citations
Specific cleavage of dynein heavy chains by ultraviolet irradiation in the presence of ATP and vanadate
Journal of Biological Chemistry · 1986 · 84 citations
RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis
International Forum of Allergy & Rhinology · 2014 · 59 citations

JS
Jose Stolovitzky
13 papers
Joseph Han
8 papers
SS
Stacey Silvers
8 papers
David Yen
7 papers
Douglas Sidle
6 papers
Mas Takashima
6 papers
AG
Andrew Gould
5 papers
NB
Nadim Bikhazi
5 papers
Amber Luong
4 papers
CS
Charles Syms
4 papers
GD
Greg Davis
4 papers
JA
John Ansley
4 papers

Clinical trials

Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)
Principal investigator · Completed · Phase 2, Phase 3
Hill Dermaceuticals, Inc.
2020–2021
Safety and Performance of the Steroid-Releasing S8 Sinus Implant
Principal investigator · Completed · Phase 2
Intersect ENT
2013
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Site PI · Recruiting · Phase 3
Optinose US Inc.
2025–2028
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2024–2028